Mark Gilchrist

6.5k total citations · 1 hit paper
94 papers, 4.2k citations indexed

About

Mark Gilchrist is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Mark Gilchrist has authored 94 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 25 papers in Molecular Biology and 22 papers in Immunology. Recurrent topics in Mark Gilchrist's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Nitric Oxide and Endothelin Effects (15 papers) and Mast cells and histamine (15 papers). Mark Gilchrist is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Nitric Oxide and Endothelin Effects (15 papers) and Mast cells and histamine (15 papers). Mark Gilchrist collaborates with scholars based in United Kingdom, United States and Canada. Mark Gilchrist's co-authors include Nigel Benjamin, Paul G. Winyard, A. Dean Befus, Alan Aderem, Angela C. Shore, Andrew M. Jones, Stephen J. Bailey, Jamie R. Blackwell, Anni Vanhatalo and Kathleen A. Kennedy and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark Gilchrist

90 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4

2006 630 citations Mark Gilchrist, Alan Aderem et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Gilchrist United Kingdom	32	1.2k	1.0k	932	617	611	94	4.2k
Jiao Guo China	45	1.2k 1.0×	3.4k 3.2×	940 1.0×	453 0.7×	449 0.7×	165	7.2k
Jeong‐a Kim United States	34	1.5k 1.2×	1.9k 1.9×	488 0.5×	212 0.3×	1.1k 1.8×	93	5.7k
Abdelouahed Khalil Canada	41	940 0.8×	907 0.9×	721 0.8×	116 0.2×	254 0.4×	144	4.6k
Yan Yang China	39	617 0.5×	2.1k 2.0×	786 0.8×	166 0.3×	473 0.8×	218	5.3k
Tannaz Jamialahmadi Iran	47	781 0.6×	2.0k 1.9×	608 0.7×	261 0.4×	531 0.9×	323	6.5k
Emmelie Å. Jansson Sweden	13	924 0.7×	1.2k 1.2×	400 0.4×	223 0.4×	306 0.5×	14	2.8k
Hannu Kankaanranta Finland	45	3.2k 2.6×	1.5k 1.4×	1.2k 1.3×	183 0.3×	249 0.4×	239	6.7k
Véronique Witko‐Sarsat France	42	1.1k 0.9×	2.2k 2.1×	2.4k 2.5×	136 0.2×	431 0.7×	110	8.9k
Maria Luisa Balestrieri Italy	43	806 0.7×	2.0k 2.0×	321 0.3×	153 0.2×	817 1.3×	148	5.7k
Bina Joe United States	37	1.5k 1.2×	2.7k 2.6×	469 0.5×	127 0.2×	501 0.8×	181	5.6k

Countries citing papers authored by Mark Gilchrist

Since Specialization

Citations

This map shows the geographic impact of Mark Gilchrist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gilchrist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gilchrist more than expected).

Fields of papers citing papers by Mark Gilchrist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gilchrist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gilchrist. The network helps show where Mark Gilchrist may publish in the future.

Co-authorship network of co-authors of Mark Gilchrist

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gilchrist. A scholar is included among the top collaborators of Mark Gilchrist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gilchrist. Mark Gilchrist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roberts, Jason A., et al.. (2024). Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review. Journal of Antimicrobial Chemotherapy. 79(9). 2083–2102. 13 indexed citations

Roberts, Jason A., Steven C. Wallis, C Jamieson, et al.. (2024). Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-Antimicrobial Resistance. 6(2). dlae056–dlae056. 3 indexed citations

Durkie, Miranda, Christopher M. Watson, Peter R. Winship, et al.. (2023). The Common PKD1 p.(Ile3167Phe) Variant Is Hypomorphic and Associated with Very Early Onset, Biallelic Polycystic Kidney Disease. Human Mutation. 2023. 1–8. 2 indexed citations

Gilchrist, Mark, et al.. (2023). Nephrotic syndrome: delays in diagnosis and a cause of pulmonary embolism not to miss. British Journal of Hospital Medicine. 84(5). 1–4. 1 indexed citations

Downes, Kevin J., Jacinda C. Abdul‐Mutakabbir, Joseph L. Kuti, et al.. (2023). International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(8). 740–777. 31 indexed citations

Downes, Kevin J., Jacinda C. Abdul‐Mutakabbir, Joseph L. Kuti, et al.. (2023). International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(8). 736–739. 9 indexed citations

McGrattan, Andrea, Blossom C. M. Stephan, Oliver M. Shannon, et al.. (2021). Independent and interactive associations of dietary nitrate and salt intake with blood pressure and cognitive function: a cross-sectional analysis in the InCHIANTI study. Australasian Journal of Paramedicine. 73(4). 491–502. 10 indexed citations

Dimitrova, Maria, Mark Gilchrist, & R.A. Seaton. (2021). Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. BMJ Open. 11(9). e049733–e049733. 45 indexed citations

Shepherd, Anthony I., Joseph T. Costello, Stephen J. Bailey, et al.. (2019). “Beet” the cold: beetroot juice supplementation improves peripheral blood flow, endothelial function, and anti-inflammatory status in individuals with Raynaud’s phenomenon. Journal of Applied Physiology. 127(5). 1478–1490. 30 indexed citations

10.

Casanova, Francesco, Damilola D. Adingupu, F. Dennette Adams, et al.. (2017). The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control. Cardiovascular Diabetology. 16(1). 114–114. 54 indexed citations

11.

Eglin, Clare, Joseph T. Costello, Stephen J. Bailey, et al.. (2017). Effects of dietary nitrate supplementation on the response to extremity cooling and endothelial function in individuals with cold sensitivity. A double blind, placebo controlled, crossover, randomised control trial. Nitric Oxide. 70. 76–85. 17 indexed citations

12.

Gilchrist, Mark, William R. Henderson, Carrie D. Johnson, et al.. (2010). A key role for ATF3 in regulating mast cell survival and mediator release. Blood. 115(23). 4734–4741. 30 indexed citations

13.

Gilchrist, Mark, Angela C. Shore, & Nigel Benjamin. (2010). Inorganic nitrate and nitrite and control of blood pressure. Cardiovascular Research. 89(3). 492–498. 74 indexed citations

14.

Gilchrist, Mark. (2009). Cutaneous Listeria infection. British Journal of Hospital Medicine. 70(11). 659–659. 5 indexed citations

15.

Gilchrist, Mark, William R. Henderson, April Clark, et al.. (2008). Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation. The Journal of Experimental Medicine. 205(10). 2349–2357. 83 indexed citations

16.

Pelle, Benjamin, Mark Gilchrist, W. Lawson, Ann Jacklin, & Bryony Dean Franklin. (2006). Using defined daily doses to study the use of antibacterials in UK hospitals. UCL Discovery (University College London). 7 indexed citations

17.

Nohara, Osamu, et al.. (2001). Regulation of CD8 Expression in Mast Cells by Exogenous or Endogenous Nitric Oxide. The Journal of Immunology. 167(10). 5935–5939. 9 indexed citations

18.

Lin, Tong‐Jun, Grant R. Stenton, Mark Gilchrist, et al.. (2000). Activation of Macrophage CD8: Pharmacological Studies of TNF and IL-1β Production. The Journal of Immunology. 164(4). 1783–1792. 30 indexed citations

19.

Lin, Tong‐Jun, Mark Gilchrist, Osamu Nohara, et al.. (1999). Novel CD8 Molecule on Macrophages and Mast Cells: Expression, Function and Signaling. International Archives of Allergy and Immunology. 118(2-4). 180–182. 16 indexed citations

20.

Lin, Tong‐Jun, et al.. (1998). Mast Cells Express Novel CD8 Molecules That Selectively Modulate Mediator Secretion. The Journal of Immunology. 161(11). 6265–6272. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact